Pnc Financial Services Group, Inc. Allakos Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$1.72 - $3.18 $168 - $311	-98 Reduced 43.36%	128 $0
Q3 2023 Nov 13, 2023	SELL	$2.13 - $5.55 $1,588 - $4,140	-746 Reduced 76.75%	226 $0
Q2 2022 Aug 12, 2022	BUY	$2.6 - $6.14 $2,230 - $5,268	858 Added 752.63%	972 $3,000
Q1 2022 May 12, 2022	BUY	$5.08 - $9.81 $579 - $1,118	114 New	114 $0

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.